Acesion Pharma is a developer of medical drugs designed for the treatment of atrial fibrillation.
Acesion Pharma has raised $47.6M in total funding. The most recent round was Series B. The last funding was announced in September 2023.
Acesion Pharma's investors include Canaan Partners, Alpha Wave Global, Novo Holdings, Seed Capital, Wellcome Trust.
Acesion Pharma is headquartered in Frederiksberg, Denmark.
Acesion Pharma is a developer of medical drugs designed for the treatment of atrial fibrillation.
Acesion Pharma is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Acesion Pharma — Funding & Investors." VCBacked, September 26, 2023, https://www.vcbacked.co/company/acesion-pharma. Accessed August 7, 2026.
VCBacked. (2023). Acesion Pharma — Funding & Investors. Retrieved August 7, 2026, from https://www.vcbacked.co/company/acesion-pharma
{{cite web |title=Acesion Pharma — Funding & Investors |url=https://www.vcbacked.co/company/acesion-pharma |website=VCBacked |access-date=August 7, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated